Colon & Rectal Surgery · Oklahoma City, OK
NPI
1598720013
Since 2006
Specialty
Colon & Rectal Surgery
Code 208C00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4200 W Memorial Rd, Ste 909
Oklahoma City, OK, 73120
Phone (405) 749-4201
Groups this clinician bills Medicare through
Medicare paid, 2024
$586K
2,259 services
Medicare patients, 2024
523
Average age 75
Drug cost, 2024
$196K
1,283 prescriptions
Company payments, 2025
$892
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit P Saha was code 99214 (office e&m - established), 499 times for 254 patients. In total Amit P Saha billed 2,259 services in 72 codes, and Medicare paid $586K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 499 | 254 | $85.87 | $43K |
| 99213 Office E&M - Established | Office | 423 | 246 | $58.40 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 307 | 70 | $53.94 | $17K |
| 45380 Lower GI Endoscopy - Other | Facility | 121 | 119 | $87.18 | $11K |
| 99223 Hospital E&M - Initial | Facility | 94 | 84 | $119.58 | $11K |
| 99203 Office E&M - New | Office | 87 | 87 | $75.31 | $6,552 |
| 45385 Colonoscopy - Lesion Removal | Facility | 52 | 51 | $160.78 | $8,361 |
| 46221 Digestive/Gastrointestinal | Office | 48 | 27 | $190.10 | $9,125 |
| 99204 Office E&M - New | Office | 33 | 33 | $115.10 | $3,798 |
| 46600 Digestive/Gastrointestinal | Office | 29 | 26 | $72.76 | $2,110 |
| 46221 Digestive/Gastrointestinal | Facility | 21 | 21 | $81.09 | $1,703 |
| 44207 Digestive/Gastrointestinal | Facility | 18 | 18 | $1,231.41 | $22K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 14 | 14 | $36.43 | $510 |
| 45378 Lower GI Endoscopy - Other | Facility | 14 | 14 | $96.30 | $1,348 |
| 99215 Office E&M - Established | Office | 13 | 11 | $124.10 | $1,613 |
By year: 2022 $368K for 2,447 services; 2023 $3.0M for 4,733 services; 2024 $586K for 2,259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit P Saha prescribed most often to Medicare patients was Metronidazole, with 185 prescriptions and refills. In total Amit P Saha wrote 1,283 Medicare prescriptions that cost $196K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metronidazole Generic | 185 | 185 | 110 | $959 |
| Pantoprazole Sodium Generic | 150 | 240 | 50 | $1,782 |
| Colestipol Hcl Generic | 139 | 255 | 52 | $5,261 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 89 | 89 | 44 | $852 |
| Mesalamine Generic | 71 | 132 | 31 | $24K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 59 | 59 | 45 | $768 |
| Dicyclomine Hcl Generic | 58 | 107 | 22 | $1,135 |
| Movantik Naloxegol Oxalate | 47 | 57 | 11 | $23K |
| Vancomycin Hcl Generic | 36 | 36 | 13 | $3,053 |
| Nystatin Generic | 33 | 34 | 20 | $362 |
| Neomycin Sulfate Generic | 28 | 28 | 27 | $162 |
| Constulose Lactulose | 25 | 45 | Under 11 | $712 |
| Lactulose Generic | 25 | 50 | 15 | $559 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | 23 | $179 |
| Fluconazole Generic | 22 | 22 | 14 | $104 |
Brand drugs: 173 claims; generic drugs: 1,110 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit P Saha $892 ($892 in general payments such as food, travel and fees) from 4 companies. The largest payer was TELA Bio, Inc. with $386.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.